Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
March 16, 2023 17:14 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
March 16, 2023 09:25 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
March 09, 2023 07:00 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31,...
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
February 28, 2023 16:10 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on...
Harvard Bioscience Announces CFO Transition
December 12, 2022 08:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer...
Harvard Bioscience Announces Third Quarter 2022 Financial Results
November 08, 2022 16:01 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Jim...
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
November 02, 2022 17:15 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2022 after the market closes on...
Harvard Bioscience Announces Second Quarter 2022 Financial Results
August 03, 2022 22:48 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2022. Jim Green,...
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
July 26, 2022 16:50 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2022 before the market opens on...
Harvard Bioscience Announces First Quarter 2022 Financial Results
May 04, 2022 07:00 ET
|
Harvard Bioscience, Inc.
•Revenue up 7% year-over-year despite volatility in China related to COVID-19 and global supply chain headwinds HOLLISTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:...